1. Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT.
- Author
-
Ghodsian M, Obrzut SL, Hyde CC, Watts WJ, and Schiepers C
- Subjects
- Adolescent, Brain Neoplasms complications, Female, Humans, Lower Extremity diagnostic imaging, Meningioma complications, Pain diagnosis, Pain etiology, Radiopharmaceuticals, Sacrum diagnostic imaging, Spasm diagnosis, Spasm etiology, Brain Neoplasms diagnosis, Fluorodeoxyglucose F18, Meningioma diagnosis, Meningioma secondary, Positron-Emission Tomography methods, Spinal Neoplasms diagnosis, Spinal Neoplasms secondary, Tomography, X-Ray Computed methods
- Abstract
Purpose: The purpose of this study was to characterize the 2-deoxy-2-[18F]fluoro-D-glucose (FDG) PET/CT imaging findings of sacral metastatic meningioma., Materials and Methods: An 18-year-old woman with a history of metastatic meningioma, who presented with intractable pain and spasm of the right lower extremity, underwent FDG PET/CT imaging., Results: FDG PET/CT scan demonstrated a moderately hypermetabolic sacral mass. The biopsy of the lesion was consistent with a high-grade malignant meningioma., Conclusions: Although meningioma is typically a benign tumor, in rare instances, it metastasizes. The current case example exhibits moderately increased metabolism despite findings of high-grade malignancy on biopsy.
- Published
- 2005
- Full Text
- View/download PDF